Unleashing the Power
of Precision Biologics
Carl Gordon, Ph.D., C.F.A.
Chairman
© 2025 Sidewinder Therapeutics. All Rights Reserved. Terms of Use | Privacy Notice
About Sidewinder
Sidewinder Therapeutics is pioneering the next generation of large molecule precision therapeutics.
We aim to deliver new life-saving therapies for patients with cancer and rare disease. Built by a dynamic team of serial entrepreneurs and expert scientists and drug developers, we are advancing innovative medicines targeting highly specific molecular drivers of disease.
Leadership Team
The Sidewinder Team has extensive experience in drug discovery and development and is committed to delivering therapies to improve the lives of patients.
Board of Directors
Ryan Corcoran, M.D., Ph.D.
Director & Co-Founder
Eric Murphy, Ph.D.
Director & Co-Founder
Jean-Pierre Wery, Ph.D.
Director & Co-Founder
Our Investors
Jean-Pierre Wery, Ph.D.
/in Leadership TeamCo-Founder, Director, President & Chief Executive Officer
Rob McRae
/in Leadership TeamChief Operating Officer
Davy Ouyang, Ph.D.
/in Leadership TeamExecutive Vice President, Research and Development
Ziyong Sun, Ph.D.
/in Leadership TeamExecutive Vice President, Biologics Discovery
Nicole Niu, Ph.D.
/in Leadership TeamVice President, Program Management